Trial intelligence / Profile preview

Propofol versus sevoflurane for ventilation-perfusion matching during general anaesthesia

ACTRN12614000226606Phase 4Not yet recruiting

Sponsor
Austin Health
Start
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of propofol and sevoflurane (2 arms), sponsored by Austin Health. Primary endpoint: Change in ventilation-perfusion scatter indexed by d log SD. Planned start Feb 2015; status: not yet recruiting.

02

Drugs

propofolsevoflurane

Beyond the preview

Go deeper on ACTRN12614000226606.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12614000226606.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call